Global Valganciclovir Tablets Market Growth 2026-2032
The global Valganciclovir Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Valganciclovir hydrochloride is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus retinitis (CMV retinitis) in adults with AIDS.
United States market for Valganciclovir Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Valganciclovir Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Valganciclovir Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Valganciclovir Tablets players cover Ajanta Pharma USA Inc., Dr. Reddy?s Laboratories Inc., Cheplapharm Arzneimittel GmbH, Extrovis AG, Pharmathen SA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Valganciclovir Tablets Industry Forecast? looks at past sales and reviews total world Valganciclovir Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Valganciclovir Tablets sales for 2026 through 2032. With Valganciclovir Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valganciclovir Tablets industry.
This Insight Report provides a comprehensive analysis of the global Valganciclovir Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valganciclovir Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Valganciclovir Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valganciclovir Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valganciclovir Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Valganciclovir Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Valganciclovir hydrochloride is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus retinitis (CMV retinitis) in adults with AIDS.
United States market for Valganciclovir Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Valganciclovir Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Valganciclovir Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Valganciclovir Tablets players cover Ajanta Pharma USA Inc., Dr. Reddy?s Laboratories Inc., Cheplapharm Arzneimittel GmbH, Extrovis AG, Pharmathen SA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Valganciclovir Tablets Industry Forecast? looks at past sales and reviews total world Valganciclovir Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Valganciclovir Tablets sales for 2026 through 2032. With Valganciclovir Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valganciclovir Tablets industry.
This Insight Report provides a comprehensive analysis of the global Valganciclovir Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Valganciclovir Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Valganciclovir Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valganciclovir Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valganciclovir Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Valganciclovir Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 450mg
- 900mg
- Online Sales
- Offline Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ajanta Pharma USA Inc.
- Dr. Reddy?s Laboratories Inc.
- Cheplapharm Arzneimittel GmbH
- Extrovis AG
- Pharmathen SA
- Viatris
- Hoffmann-La Roche
- Patheon
- Yifan Pharmaceutical
- Hubei Gedian Humanwell Pharmaceutical
- What is the 10-year outlook for the global Valganciclovir Tablets market?
- What factors are driving Valganciclovir Tablets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Valganciclovir Tablets market opportunities vary by end market size?
- How does Valganciclovir Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valganciclovir Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Valganciclovir Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Valganciclovir Tablets by Country/Region, 2021, 2025 & 2032
2.2 Valganciclovir Tablets Segment by Type
2.2.1 450mg
2.2.2 900mg
2.2.3 Valganciclovir Tablets Sales by Type
2.2.3.1 Global Valganciclovir Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Valganciclovir Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Valganciclovir Tablets Sale Price by Type (2021-2026)
2.3 Valganciclovir Tablets Segment by Application
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Valganciclovir Tablets Sales by Application
2.3.3.1 Global Valganciclovir Tablets Sale Market Share by Application (2021-2026)
2.3.3.2 Global Valganciclovir Tablets Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Valganciclovir Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Valganciclovir Tablets Breakdown Data by Company
3.1.1 Global Valganciclovir Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Valganciclovir Tablets Sales Market Share by Company (2021-2026)
3.2 Global Valganciclovir Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Valganciclovir Tablets Revenue by Company (2021-2026)
3.2.2 Global Valganciclovir Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Valganciclovir Tablets Sale Price by Company
3.4 Key Manufacturers Valganciclovir Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valganciclovir Tablets Product Location Distribution
3.4.2 Players Valganciclovir Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VALGANCICLOVIR TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Valganciclovir Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Valganciclovir Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Valganciclovir Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Valganciclovir Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Valganciclovir Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Valganciclovir Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Valganciclovir Tablets Sales Growth
4.4 APAC Valganciclovir Tablets Sales Growth
4.5 Europe Valganciclovir Tablets Sales Growth
4.6 Middle East & Africa Valganciclovir Tablets Sales Growth
5 AMERICAS
5.1 Americas Valganciclovir Tablets Sales by Country
5.1.1 Americas Valganciclovir Tablets Sales by Country (2021-2026)
5.1.2 Americas Valganciclovir Tablets Revenue by Country (2021-2026)
5.2 Americas Valganciclovir Tablets Sales by Type (2021-2026)
5.3 Americas Valganciclovir Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valganciclovir Tablets Sales by Region
6.1.1 APAC Valganciclovir Tablets Sales by Region (2021-2026)
6.1.2 APAC Valganciclovir Tablets Revenue by Region (2021-2026)
6.2 APAC Valganciclovir Tablets Sales by Type (2021-2026)
6.3 APAC Valganciclovir Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Valganciclovir Tablets by Country
7.1.1 Europe Valganciclovir Tablets Sales by Country (2021-2026)
7.1.2 Europe Valganciclovir Tablets Revenue by Country (2021-2026)
7.2 Europe Valganciclovir Tablets Sales by Type (2021-2026)
7.3 Europe Valganciclovir Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valganciclovir Tablets by Country
8.1.1 Middle East & Africa Valganciclovir Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Valganciclovir Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Valganciclovir Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Valganciclovir Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valganciclovir Tablets
10.3 Manufacturing Process Analysis of Valganciclovir Tablets
10.4 Industry Chain Structure of Valganciclovir Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valganciclovir Tablets Distributors
11.3 Valganciclovir Tablets Customer
12 WORLD FORECAST REVIEW FOR VALGANCICLOVIR TABLETS BY GEOGRAPHIC REGION
12.1 Global Valganciclovir Tablets Market Size Forecast by Region
12.1.1 Global Valganciclovir Tablets Forecast by Region (2027-2032)
12.1.2 Global Valganciclovir Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Valganciclovir Tablets Forecast by Type (2027-2032)
12.7 Global Valganciclovir Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ajanta Pharma USA Inc.
13.1.1 Ajanta Pharma USA Inc. Company Information
13.1.2 Ajanta Pharma USA Inc. Valganciclovir Tablets Product Portfolios and Specifications
13.1.3 Ajanta Pharma USA Inc. Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ajanta Pharma USA Inc. Main Business Overview
13.1.5 Ajanta Pharma USA Inc. Latest Developments
13.2 Dr. Reddy?s Laboratories Inc.
13.2.1 Dr. Reddy?s Laboratories Inc. Company Information
13.2.2 Dr. Reddy?s Laboratories Inc. Valganciclovir Tablets Product Portfolios and Specifications
13.2.3 Dr. Reddy?s Laboratories Inc. Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Dr. Reddy?s Laboratories Inc. Main Business Overview
13.2.5 Dr. Reddy?s Laboratories Inc. Latest Developments
13.3 Cheplapharm Arzneimittel GmbH
13.3.1 Cheplapharm Arzneimittel GmbH Company Information
13.3.2 Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Product Portfolios and Specifications
13.3.3 Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Cheplapharm Arzneimittel GmbH Main Business Overview
13.3.5 Cheplapharm Arzneimittel GmbH Latest Developments
13.4 Extrovis AG
13.4.1 Extrovis AG Company Information
13.4.2 Extrovis AG Valganciclovir Tablets Product Portfolios and Specifications
13.4.3 Extrovis AG Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Extrovis AG Main Business Overview
13.4.5 Extrovis AG Latest Developments
13.5 Pharmathen SA
13.5.1 Pharmathen SA Company Information
13.5.2 Pharmathen SA Valganciclovir Tablets Product Portfolios and Specifications
13.5.3 Pharmathen SA Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pharmathen SA Main Business Overview
13.5.5 Pharmathen SA Latest Developments
13.6 Viatris
13.6.1 Viatris Company Information
13.6.2 Viatris Valganciclovir Tablets Product Portfolios and Specifications
13.6.3 Viatris Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Viatris Main Business Overview
13.6.5 Viatris Latest Developments
13.7 Hoffmann-La Roche
13.7.1 Hoffmann-La Roche Company Information
13.7.2 Hoffmann-La Roche Valganciclovir Tablets Product Portfolios and Specifications
13.7.3 Hoffmann-La Roche Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hoffmann-La Roche Main Business Overview
13.7.5 Hoffmann-La Roche Latest Developments
13.8 Patheon
13.8.1 Patheon Company Information
13.8.2 Patheon Valganciclovir Tablets Product Portfolios and Specifications
13.8.3 Patheon Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Patheon Main Business Overview
13.8.5 Patheon Latest Developments
13.9 Yifan Pharmaceutical
13.9.1 Yifan Pharmaceutical Company Information
13.9.2 Yifan Pharmaceutical Valganciclovir Tablets Product Portfolios and Specifications
13.9.3 Yifan Pharmaceutical Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Yifan Pharmaceutical Main Business Overview
13.9.5 Yifan Pharmaceutical Latest Developments
13.10 Hubei Gedian Humanwell Pharmaceutical
13.10.1 Hubei Gedian Humanwell Pharmaceutical Company Information
13.10.2 Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Product Portfolios and Specifications
13.10.3 Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hubei Gedian Humanwell Pharmaceutical Main Business Overview
13.10.5 Hubei Gedian Humanwell Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valganciclovir Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Valganciclovir Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Valganciclovir Tablets by Country/Region, 2021, 2025 & 2032
2.2 Valganciclovir Tablets Segment by Type
2.2.1 450mg
2.2.2 900mg
2.2.3 Valganciclovir Tablets Sales by Type
2.2.3.1 Global Valganciclovir Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Valganciclovir Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Valganciclovir Tablets Sale Price by Type (2021-2026)
2.3 Valganciclovir Tablets Segment by Application
2.3.1 Online Sales
2.3.2 Offline Sales
2.3.3 Valganciclovir Tablets Sales by Application
2.3.3.1 Global Valganciclovir Tablets Sale Market Share by Application (2021-2026)
2.3.3.2 Global Valganciclovir Tablets Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Valganciclovir Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Valganciclovir Tablets Breakdown Data by Company
3.1.1 Global Valganciclovir Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Valganciclovir Tablets Sales Market Share by Company (2021-2026)
3.2 Global Valganciclovir Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Valganciclovir Tablets Revenue by Company (2021-2026)
3.2.2 Global Valganciclovir Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Valganciclovir Tablets Sale Price by Company
3.4 Key Manufacturers Valganciclovir Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valganciclovir Tablets Product Location Distribution
3.4.2 Players Valganciclovir Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VALGANCICLOVIR TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Valganciclovir Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Valganciclovir Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Valganciclovir Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Valganciclovir Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Valganciclovir Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Valganciclovir Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Valganciclovir Tablets Sales Growth
4.4 APAC Valganciclovir Tablets Sales Growth
4.5 Europe Valganciclovir Tablets Sales Growth
4.6 Middle East & Africa Valganciclovir Tablets Sales Growth
5 AMERICAS
5.1 Americas Valganciclovir Tablets Sales by Country
5.1.1 Americas Valganciclovir Tablets Sales by Country (2021-2026)
5.1.2 Americas Valganciclovir Tablets Revenue by Country (2021-2026)
5.2 Americas Valganciclovir Tablets Sales by Type (2021-2026)
5.3 Americas Valganciclovir Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valganciclovir Tablets Sales by Region
6.1.1 APAC Valganciclovir Tablets Sales by Region (2021-2026)
6.1.2 APAC Valganciclovir Tablets Revenue by Region (2021-2026)
6.2 APAC Valganciclovir Tablets Sales by Type (2021-2026)
6.3 APAC Valganciclovir Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Valganciclovir Tablets by Country
7.1.1 Europe Valganciclovir Tablets Sales by Country (2021-2026)
7.1.2 Europe Valganciclovir Tablets Revenue by Country (2021-2026)
7.2 Europe Valganciclovir Tablets Sales by Type (2021-2026)
7.3 Europe Valganciclovir Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valganciclovir Tablets by Country
8.1.1 Middle East & Africa Valganciclovir Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Valganciclovir Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Valganciclovir Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Valganciclovir Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valganciclovir Tablets
10.3 Manufacturing Process Analysis of Valganciclovir Tablets
10.4 Industry Chain Structure of Valganciclovir Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valganciclovir Tablets Distributors
11.3 Valganciclovir Tablets Customer
12 WORLD FORECAST REVIEW FOR VALGANCICLOVIR TABLETS BY GEOGRAPHIC REGION
12.1 Global Valganciclovir Tablets Market Size Forecast by Region
12.1.1 Global Valganciclovir Tablets Forecast by Region (2027-2032)
12.1.2 Global Valganciclovir Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Valganciclovir Tablets Forecast by Type (2027-2032)
12.7 Global Valganciclovir Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Ajanta Pharma USA Inc.
13.1.1 Ajanta Pharma USA Inc. Company Information
13.1.2 Ajanta Pharma USA Inc. Valganciclovir Tablets Product Portfolios and Specifications
13.1.3 Ajanta Pharma USA Inc. Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Ajanta Pharma USA Inc. Main Business Overview
13.1.5 Ajanta Pharma USA Inc. Latest Developments
13.2 Dr. Reddy?s Laboratories Inc.
13.2.1 Dr. Reddy?s Laboratories Inc. Company Information
13.2.2 Dr. Reddy?s Laboratories Inc. Valganciclovir Tablets Product Portfolios and Specifications
13.2.3 Dr. Reddy?s Laboratories Inc. Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Dr. Reddy?s Laboratories Inc. Main Business Overview
13.2.5 Dr. Reddy?s Laboratories Inc. Latest Developments
13.3 Cheplapharm Arzneimittel GmbH
13.3.1 Cheplapharm Arzneimittel GmbH Company Information
13.3.2 Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Product Portfolios and Specifications
13.3.3 Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Cheplapharm Arzneimittel GmbH Main Business Overview
13.3.5 Cheplapharm Arzneimittel GmbH Latest Developments
13.4 Extrovis AG
13.4.1 Extrovis AG Company Information
13.4.2 Extrovis AG Valganciclovir Tablets Product Portfolios and Specifications
13.4.3 Extrovis AG Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Extrovis AG Main Business Overview
13.4.5 Extrovis AG Latest Developments
13.5 Pharmathen SA
13.5.1 Pharmathen SA Company Information
13.5.2 Pharmathen SA Valganciclovir Tablets Product Portfolios and Specifications
13.5.3 Pharmathen SA Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pharmathen SA Main Business Overview
13.5.5 Pharmathen SA Latest Developments
13.6 Viatris
13.6.1 Viatris Company Information
13.6.2 Viatris Valganciclovir Tablets Product Portfolios and Specifications
13.6.3 Viatris Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Viatris Main Business Overview
13.6.5 Viatris Latest Developments
13.7 Hoffmann-La Roche
13.7.1 Hoffmann-La Roche Company Information
13.7.2 Hoffmann-La Roche Valganciclovir Tablets Product Portfolios and Specifications
13.7.3 Hoffmann-La Roche Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hoffmann-La Roche Main Business Overview
13.7.5 Hoffmann-La Roche Latest Developments
13.8 Patheon
13.8.1 Patheon Company Information
13.8.2 Patheon Valganciclovir Tablets Product Portfolios and Specifications
13.8.3 Patheon Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Patheon Main Business Overview
13.8.5 Patheon Latest Developments
13.9 Yifan Pharmaceutical
13.9.1 Yifan Pharmaceutical Company Information
13.9.2 Yifan Pharmaceutical Valganciclovir Tablets Product Portfolios and Specifications
13.9.3 Yifan Pharmaceutical Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Yifan Pharmaceutical Main Business Overview
13.9.5 Yifan Pharmaceutical Latest Developments
13.10 Hubei Gedian Humanwell Pharmaceutical
13.10.1 Hubei Gedian Humanwell Pharmaceutical Company Information
13.10.2 Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Product Portfolios and Specifications
13.10.3 Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hubei Gedian Humanwell Pharmaceutical Main Business Overview
13.10.5 Hubei Gedian Humanwell Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Valganciclovir Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Valganciclovir Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 450mg
Table 4. Major Players of 900mg
Table 5. Global Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Valganciclovir Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Valganciclovir Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Valganciclovir Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Valganciclovir Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Valganciclovir Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Valganciclovir Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Valganciclovir Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Valganciclovir Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Valganciclovir Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Valganciclovir Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Valganciclovir Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Valganciclovir Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Valganciclovir Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Valganciclovir Tablets Producing Area Distribution and Sales Area
Table 21. Players Valganciclovir Tablets Products Offered
Table 22. Valganciclovir Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Valganciclovir Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Valganciclovir Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Valganciclovir Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Valganciclovir Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Valganciclovir Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Valganciclovir Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Valganciclovir Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Valganciclovir Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Valganciclovir Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Valganciclovir Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Valganciclovir Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Valganciclovir Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Valganciclovir Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Valganciclovir Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Valganciclovir Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Valganciclovir Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Valganciclovir Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Valganciclovir Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Valganciclovir Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Valganciclovir Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Valganciclovir Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Valganciclovir Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Valganciclovir Tablets
Table 52. Key Market Challenges & Risks of Valganciclovir Tablets
Table 53. Key Industry Trends of Valganciclovir Tablets
Table 54. Valganciclovir Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Valganciclovir Tablets Distributors List
Table 57. Valganciclovir Tablets Customer List
Table 58. Global Valganciclovir Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Valganciclovir Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Valganciclovir Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Valganciclovir Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Valganciclovir Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Valganciclovir Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Valganciclovir Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Valganciclovir Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Valganciclovir Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Valganciclovir Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Valganciclovir Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Valganciclovir Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Valganciclovir Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Valganciclovir Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Ajanta Pharma USA Inc. Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Ajanta Pharma USA Inc. Valganciclovir Tablets Product Portfolios and Specifications
Table 74. Ajanta Pharma USA Inc. Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Ajanta Pharma USA Inc. Main Business
Table 76. Ajanta Pharma USA Inc. Latest Developments
Table 77. Dr. Reddy?s Laboratories Inc. Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Dr. Reddy?s Laboratories Inc. Valganciclovir Tablets Product Portfolios and Specifications
Table 79. Dr. Reddy?s Laboratories Inc. Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Dr. Reddy?s Laboratories Inc. Main Business
Table 81. Dr. Reddy?s Laboratories Inc. Latest Developments
Table 82. Cheplapharm Arzneimittel GmbH Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Product Portfolios and Specifications
Table 84. Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Cheplapharm Arzneimittel GmbH Main Business
Table 86. Cheplapharm Arzneimittel GmbH Latest Developments
Table 87. Extrovis AG Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Extrovis AG Valganciclovir Tablets Product Portfolios and Specifications
Table 89. Extrovis AG Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Extrovis AG Main Business
Table 91. Extrovis AG Latest Developments
Table 92. Pharmathen SA Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Pharmathen SA Valganciclovir Tablets Product Portfolios and Specifications
Table 94. Pharmathen SA Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Pharmathen SA Main Business
Table 96. Pharmathen SA Latest Developments
Table 97. Viatris Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Viatris Valganciclovir Tablets Product Portfolios and Specifications
Table 99. Viatris Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Viatris Main Business
Table 101. Viatris Latest Developments
Table 102. Hoffmann-La Roche Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Hoffmann-La Roche Valganciclovir Tablets Product Portfolios and Specifications
Table 104. Hoffmann-La Roche Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Hoffmann-La Roche Main Business
Table 106. Hoffmann-La Roche Latest Developments
Table 107. Patheon Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Patheon Valganciclovir Tablets Product Portfolios and Specifications
Table 109. Patheon Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Patheon Main Business
Table 111. Patheon Latest Developments
Table 112. Yifan Pharmaceutical Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Yifan Pharmaceutical Valganciclovir Tablets Product Portfolios and Specifications
Table 114. Yifan Pharmaceutical Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Yifan Pharmaceutical Main Business
Table 116. Yifan Pharmaceutical Latest Developments
Table 117. Hubei Gedian Humanwell Pharmaceutical Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Product Portfolios and Specifications
Table 119. Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Hubei Gedian Humanwell Pharmaceutical Main Business
Table 121. Hubei Gedian Humanwell Pharmaceutical Latest Developments
Table 1. Valganciclovir Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Valganciclovir Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 450mg
Table 4. Major Players of 900mg
Table 5. Global Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Valganciclovir Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Valganciclovir Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Valganciclovir Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Valganciclovir Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Valganciclovir Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Valganciclovir Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Valganciclovir Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Valganciclovir Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Valganciclovir Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Valganciclovir Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Valganciclovir Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Valganciclovir Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Valganciclovir Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Valganciclovir Tablets Producing Area Distribution and Sales Area
Table 21. Players Valganciclovir Tablets Products Offered
Table 22. Valganciclovir Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Valganciclovir Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Valganciclovir Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Valganciclovir Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Valganciclovir Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Valganciclovir Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Valganciclovir Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Valganciclovir Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Valganciclovir Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Valganciclovir Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Valganciclovir Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Valganciclovir Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Valganciclovir Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Valganciclovir Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Valganciclovir Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Valganciclovir Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Valganciclovir Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Valganciclovir Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Valganciclovir Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Valganciclovir Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Valganciclovir Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Valganciclovir Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Valganciclovir Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Valganciclovir Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Valganciclovir Tablets
Table 52. Key Market Challenges & Risks of Valganciclovir Tablets
Table 53. Key Industry Trends of Valganciclovir Tablets
Table 54. Valganciclovir Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Valganciclovir Tablets Distributors List
Table 57. Valganciclovir Tablets Customer List
Table 58. Global Valganciclovir Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Valganciclovir Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Valganciclovir Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Valganciclovir Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Valganciclovir Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Valganciclovir Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Valganciclovir Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Valganciclovir Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Valganciclovir Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Valganciclovir Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Valganciclovir Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Valganciclovir Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Valganciclovir Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Valganciclovir Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Ajanta Pharma USA Inc. Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Ajanta Pharma USA Inc. Valganciclovir Tablets Product Portfolios and Specifications
Table 74. Ajanta Pharma USA Inc. Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Ajanta Pharma USA Inc. Main Business
Table 76. Ajanta Pharma USA Inc. Latest Developments
Table 77. Dr. Reddy?s Laboratories Inc. Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Dr. Reddy?s Laboratories Inc. Valganciclovir Tablets Product Portfolios and Specifications
Table 79. Dr. Reddy?s Laboratories Inc. Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Dr. Reddy?s Laboratories Inc. Main Business
Table 81. Dr. Reddy?s Laboratories Inc. Latest Developments
Table 82. Cheplapharm Arzneimittel GmbH Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Product Portfolios and Specifications
Table 84. Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Cheplapharm Arzneimittel GmbH Main Business
Table 86. Cheplapharm Arzneimittel GmbH Latest Developments
Table 87. Extrovis AG Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Extrovis AG Valganciclovir Tablets Product Portfolios and Specifications
Table 89. Extrovis AG Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Extrovis AG Main Business
Table 91. Extrovis AG Latest Developments
Table 92. Pharmathen SA Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Pharmathen SA Valganciclovir Tablets Product Portfolios and Specifications
Table 94. Pharmathen SA Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Pharmathen SA Main Business
Table 96. Pharmathen SA Latest Developments
Table 97. Viatris Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Viatris Valganciclovir Tablets Product Portfolios and Specifications
Table 99. Viatris Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Viatris Main Business
Table 101. Viatris Latest Developments
Table 102. Hoffmann-La Roche Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Hoffmann-La Roche Valganciclovir Tablets Product Portfolios and Specifications
Table 104. Hoffmann-La Roche Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Hoffmann-La Roche Main Business
Table 106. Hoffmann-La Roche Latest Developments
Table 107. Patheon Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Patheon Valganciclovir Tablets Product Portfolios and Specifications
Table 109. Patheon Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Patheon Main Business
Table 111. Patheon Latest Developments
Table 112. Yifan Pharmaceutical Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Yifan Pharmaceutical Valganciclovir Tablets Product Portfolios and Specifications
Table 114. Yifan Pharmaceutical Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Yifan Pharmaceutical Main Business
Table 116. Yifan Pharmaceutical Latest Developments
Table 117. Hubei Gedian Humanwell Pharmaceutical Basic Information, Valganciclovir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Product Portfolios and Specifications
Table 119. Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Hubei Gedian Humanwell Pharmaceutical Main Business
Table 121. Hubei Gedian Humanwell Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Valganciclovir Tablets
Figure 2. Valganciclovir Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valganciclovir Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Valganciclovir Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Valganciclovir Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Valganciclovir Tablets Sales Market Share by Country/Region (2025)
Figure 10. Valganciclovir Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 450mg
Figure 12. Product Picture of 900mg
Figure 13. Global Valganciclovir Tablets Sales Market Share by Type in 2026
Figure 14. Global Valganciclovir Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Valganciclovir Tablets Consumed in Online Sales
Figure 16. Global Valganciclovir Tablets Market: Online Sales (2021-2026) & (K Units)
Figure 17. Valganciclovir Tablets Consumed in Offline Sales
Figure 18. Global Valganciclovir Tablets Market: Offline Sales (2021-2026) & (K Units)
Figure 19. Global Valganciclovir Tablets Sale Market Share by Application (2025)
Figure 20. Global Valganciclovir Tablets Revenue Market Share by Application in 2026
Figure 21. Valganciclovir Tablets Sales by Company in 2026 (K Units)
Figure 22. Global Valganciclovir Tablets Sales Market Share by Company in 2026
Figure 23. Valganciclovir Tablets Revenue by Company in 2026 ($ millions)
Figure 24. Global Valganciclovir Tablets Revenue Market Share by Company in 2026
Figure 25. Global Valganciclovir Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Valganciclovir Tablets Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Valganciclovir Tablets Sales 2021-2026 (K Units)
Figure 28. Americas Valganciclovir Tablets Revenue 2021-2026 ($ millions)
Figure 29. APAC Valganciclovir Tablets Sales 2021-2026 (K Units)
Figure 30. APAC Valganciclovir Tablets Revenue 2021-2026 ($ millions)
Figure 31. Europe Valganciclovir Tablets Sales 2021-2026 (K Units)
Figure 32. Europe Valganciclovir Tablets Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Valganciclovir Tablets Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Valganciclovir Tablets Revenue 2021-2026 ($ millions)
Figure 35. Americas Valganciclovir Tablets Sales Market Share by Country in 2026
Figure 36. Americas Valganciclovir Tablets Revenue Market Share by Country (2021-2026)
Figure 37. Americas Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Figure 38. Americas Valganciclovir Tablets Sales Market Share by Application (2021-2026)
Figure 39. United States Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Valganciclovir Tablets Sales Market Share by Region in 2026
Figure 44. APAC Valganciclovir Tablets Revenue Market Share by Region (2021-2026)
Figure 45. APAC Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Figure 46. APAC Valganciclovir Tablets Sales Market Share by Application (2021-2026)
Figure 47. China Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. India Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Valganciclovir Tablets Sales Market Share by Country in 2026
Figure 55. Europe Valganciclovir Tablets Revenue Market Share by Country (2021-2026)
Figure 56. Europe Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Figure 57. Europe Valganciclovir Tablets Sales Market Share by Application (2021-2026)
Figure 58. Germany Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 59. France Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Valganciclovir Tablets Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Valganciclovir Tablets Sales Market Share by Application (2021-2026)
Figure 66. Egypt Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Valganciclovir Tablets in 2026
Figure 72. Manufacturing Process Analysis of Valganciclovir Tablets
Figure 73. Industry Chain Structure of Valganciclovir Tablets
Figure 74. Channels of Distribution
Figure 75. Global Valganciclovir Tablets Sales Market Forecast by Region (2027-2032)
Figure 76. Global Valganciclovir Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Valganciclovir Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Valganciclovir Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Valganciclovir Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Valganciclovir Tablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Valganciclovir Tablets
Figure 2. Valganciclovir Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valganciclovir Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Valganciclovir Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Valganciclovir Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Valganciclovir Tablets Sales Market Share by Country/Region (2025)
Figure 10. Valganciclovir Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 450mg
Figure 12. Product Picture of 900mg
Figure 13. Global Valganciclovir Tablets Sales Market Share by Type in 2026
Figure 14. Global Valganciclovir Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Valganciclovir Tablets Consumed in Online Sales
Figure 16. Global Valganciclovir Tablets Market: Online Sales (2021-2026) & (K Units)
Figure 17. Valganciclovir Tablets Consumed in Offline Sales
Figure 18. Global Valganciclovir Tablets Market: Offline Sales (2021-2026) & (K Units)
Figure 19. Global Valganciclovir Tablets Sale Market Share by Application (2025)
Figure 20. Global Valganciclovir Tablets Revenue Market Share by Application in 2026
Figure 21. Valganciclovir Tablets Sales by Company in 2026 (K Units)
Figure 22. Global Valganciclovir Tablets Sales Market Share by Company in 2026
Figure 23. Valganciclovir Tablets Revenue by Company in 2026 ($ millions)
Figure 24. Global Valganciclovir Tablets Revenue Market Share by Company in 2026
Figure 25. Global Valganciclovir Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Valganciclovir Tablets Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Valganciclovir Tablets Sales 2021-2026 (K Units)
Figure 28. Americas Valganciclovir Tablets Revenue 2021-2026 ($ millions)
Figure 29. APAC Valganciclovir Tablets Sales 2021-2026 (K Units)
Figure 30. APAC Valganciclovir Tablets Revenue 2021-2026 ($ millions)
Figure 31. Europe Valganciclovir Tablets Sales 2021-2026 (K Units)
Figure 32. Europe Valganciclovir Tablets Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Valganciclovir Tablets Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Valganciclovir Tablets Revenue 2021-2026 ($ millions)
Figure 35. Americas Valganciclovir Tablets Sales Market Share by Country in 2026
Figure 36. Americas Valganciclovir Tablets Revenue Market Share by Country (2021-2026)
Figure 37. Americas Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Figure 38. Americas Valganciclovir Tablets Sales Market Share by Application (2021-2026)
Figure 39. United States Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Valganciclovir Tablets Sales Market Share by Region in 2026
Figure 44. APAC Valganciclovir Tablets Revenue Market Share by Region (2021-2026)
Figure 45. APAC Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Figure 46. APAC Valganciclovir Tablets Sales Market Share by Application (2021-2026)
Figure 47. China Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. India Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Valganciclovir Tablets Sales Market Share by Country in 2026
Figure 55. Europe Valganciclovir Tablets Revenue Market Share by Country (2021-2026)
Figure 56. Europe Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Figure 57. Europe Valganciclovir Tablets Sales Market Share by Application (2021-2026)
Figure 58. Germany Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 59. France Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Valganciclovir Tablets Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Valganciclovir Tablets Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Valganciclovir Tablets Sales Market Share by Application (2021-2026)
Figure 66. Egypt Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Valganciclovir Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Valganciclovir Tablets in 2026
Figure 72. Manufacturing Process Analysis of Valganciclovir Tablets
Figure 73. Industry Chain Structure of Valganciclovir Tablets
Figure 74. Channels of Distribution
Figure 75. Global Valganciclovir Tablets Sales Market Forecast by Region (2027-2032)
Figure 76. Global Valganciclovir Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Valganciclovir Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Valganciclovir Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Valganciclovir Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Valganciclovir Tablets Revenue Market Share Forecast by Application (2027-2032)
